查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1507220

搔癢治療藥物市場、佔有率、規模、趨勢、產業分析報告：依疾病類型、產品、地區、細分市場預測，2024-2032年

Pruritus Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Allergic Contact Dermatitis, Atopic Dermatitis, Urticaria, Others); By Product; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年全球止癢藥物市場規模將達到132億美元。本研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於與各種皮膚和全身性疾病相關的慢性搔癢的盛行率不斷增加，搔癢治療藥物市場顯著成長。人們越來越認識到搔癢對患者的生活品質有重大影響，增加了對有效治療方案的需求。醫學的進步，特別是新生物製劑和標靶療法的發明，日益擴大搔癢症的治療範圍，並改善患者的治療效果。此外，全球人口老化，更容易感染引起持續性搔癢的疾病，進一步推動了市場成長。

主要市場趨勢包括開發和使用專門針對搔癢分子機制的生物和免疫調節劑。此外，越來越多的運動採用先進的藥物傳遞系統來提高局部治療的有效性和黏附力。

皮膚病發生率的增加是搔癢治療藥物市場的主要驅動因素。這些疾病常表現為慢性搔癢，對患者的生活品質有重大影響。都市化、污染和生活方式的改變等因素導致濕疹、牛皮癬和異位性皮膚炎等皮膚病在全球的盛行率增加，導致皮膚屏障受損和免疫力受損。此外，主要製藥公司和新興生技公司之間的激烈競爭也是搔癢治療藥物市場競爭格局的特徵。這些業界領先的公司利用先進的生物製劑、免疫調節劑和標靶療法來開發創新療法，解決搔癢的根本原因。

搔癢治療藥物市場報告亮點

2023年全球止癢藥物市場主要由異位性皮膚炎市場驅動，因為該市場患病率高且長期存在。異位性皮膚炎的主要症狀往往是嚴重且持續的搔癢。

2023年搔癢治療藥物市場，皮質類固醇的銷售佔有率最高。這主要是由於皮質類固醇在治療引起皮膚搔癢的各種發炎性皮膚病的廣泛使用和已確立的療效。

2023年，由於異位性皮膚炎、牛皮癬和濕疹等皮膚病的高發，北美成為全球市場的關鍵地區。這些疾病大幅推動了該地區對搔癢治療的需求。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球搔癢治療藥物市場洞察

  • 行業概況
  • 搔癢藥物市場動態
    • 推動因素和機會
      • 皮膚病盛行率增加
      • 生物技術與藥理學的進展
    • 抑制因素和挑戰
      • 副作用與安全性問題
  • PESTLE分析
  • 搔癢治療藥物產業的趨勢
  • 價值鏈分析
  • 新冠肺炎（COVID-19）影響分析

第5章 全球搔癢治療藥物市場：依疾病類型

  • 主要發現
  • 簡介
  • 過敏性接觸性皮膚炎
  • 異位性皮膚炎
  • 蕁麻疹
  • 其他

第6章 全球搔癢治療藥物市場：依產品

  • 主要發現
  • 簡介
  • 抗組織胺藥
  • 鈣調神經磷酸酶抑制劑
  • 皮質類固醇
  • 抗刺激劑
  • 免疫抑制劑
  • 局部麻醉劑
  • 其他

第7章 全球搔癢治療藥物市場：依地區

  • 主要發現
  • 簡介
    • 搔癢治療藥物市場評估：依地區，2019-2032
  • 北美
    • 北美：依產品分類，2019-2032年
    • 北美：依疾病類型，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依產品分類，2019-2032年
    • 歐洲：依疾病類型，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依產品分類，2019-2032年
    • 亞太地區：依疾病類型，2019-2032年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 中東與非洲：依產品分類，2019-2032年
    • 中東與非洲：依疾病類型，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依產品分類，2019-2032年
    • 拉丁美洲：依疾病類型，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協定/揭露

第9章 公司簡介

  • AbbVie Inc
  • Amgen Inc
  • Astellas Pharma Inc
  • Bristol Myers Squibb
  • Cara Therapeutics
  • GSK plc
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
Product Code: PM1301

The global Pruritus Therapeutics market size is expected to reach USD 13.2 Billion by 2032, according to a new study by Polaris Market Research. The report "Pruritus Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Allergic Contact Dermatitis, Atopic Dermatitis, Urticaria, Others); By Product; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for treating pruritus is seeing significant growth as a result of the increasing prevalence of chronic itching linked to various skin and systemic conditions. The growing awareness of pruritus's substantial impact on patient's quality of life is boosting the demand for effective treatment options. Advances in pharmaceuticals, particularly the creation of new biologics and targeted therapies, are broadening the range of treatments available for pruritus, leading to better patient outcomes. Additionally, the aging global population, which is more prone to conditions causing persistent itching, is further propelling market growth.

Key trends in the market include the development and use of biological drugs and immunomodulators that specifically target the molecular mechanisms underlying pruritus. The incorporation of advanced drug delivery systems to improve the effectiveness and adherence of topical treatments is also gaining momentum.

The rising incidence of dermatological disorders is a key driver for the pruritus therapeutics market. These conditions often manifest as chronic itching, significantly impacting patients' quality of life. Factors such as urbanization, pollution, and lifestyle changes contribute to the increasing global prevalence of skin diseases like eczema, psoriasis, and atopic dermatitis, resulting in compromised skin barriers and immune system changes. Furthermore, intense competition among major pharmaceutical companies and emerging biotech firms characterize the competitive landscape of the pruritus therapeutics market. These industry leaders are leveraging advanced biologics, immunomodulators, and targeted therapies to develop innovative treatments that address the root causes of pruritus.

Pruritus Therapeutics Market Report Highlights

The global market for pruritus therapeutics in 2023 was primarily driven by the atopic dermatitis segment, owing to the condition's high prevalence and chronicity. This condition is often characterized by severe and persistent itching as a primary symptom.

The corticosteroids segment had the highest revenue share in the pruritus therapeutics market in 2023. This was primarily due to their extensive utilization and established effectiveness in treating various inflammatory skin conditions that result in pruritus.

In 2023, North America established itself as the leading region in the global market due to its high prevalence of dermatological conditions like atopic dermatitis, psoriasis, and eczema. These conditions have significantly boosted the demand for pruritus treatments in the region.

The global key market players include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bristol Myers Squibb, Cara Therapeutics, GSK plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Viatris Inc., among others.

Polaris Market Research has segmented the pruritus therapeutics market report based on disease type, product, and region:

Pruritus Therapeutics, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Allergic Contact Dermatitis
  • Atopic Dermatitis
  • Urticaria
  • Othersc

Pruritus Therapeutics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antihistamines
  • Calcineurin Inhibitors
  • Corticosteroids
  • Counterirritants
  • Immunosuppressant
  • Local Anesthetics
  • Others

Pruritus Therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pruritus Therapeutics Market Insights

  • 4.1. Pruritus Therapeutics Market - Industry Snapshot
  • 4.2. Pruritus Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Dermatological Conditions
      • 4.2.1.2. Advances in Biotechnology and Pharmacology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse Effects and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Pruritus Therapeutics Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Pruritus Therapeutics Market, by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pruritus Therapeutics, by Disease Type, 2019-2032 (USD Billion)
  • 5.3. Allergic Contact Dermatitis
    • 5.3.1. Global Pruritus Therapeutics Market, by Allergic Contact Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.4. Atopic Dermatitis
    • 5.4.1. Global Pruritus Therapeutics Market, by Atopic Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.5. Urticaria
    • 5.5.1. Global Pruritus Therapeutics Market, by Urticaria, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Pruritus Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Pruritus Therapeutics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Antihistamines
    • 6.3.1. Global Pruritus Therapeutics Market, by Antihistamines, by Region, 2019-2032 (USD Billion)
  • 6.4. Calcineurin Inhibitors
    • 6.4.1. Global Pruritus Therapeutics Market, by Calcineurin Inhibitors, by Region, 2019-2032 (USD Billion)
  • 6.5. Corticosteroids
    • 6.5.1. Global Pruritus Therapeutics Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.6. Counterirritants
    • 6.6.1. Global Pruritus Therapeutics Market, by Counterirritants, by Region, 2019-2032 (USD Billion)
  • 6.7. Immunosuppressant
    • 6.7.1. Global Pruritus Therapeutics Market, by Immunosuppressant, by Region, 2019-2032 (USD Billion)
  • 6.8. Local Anesthetics
    • 6.8.1. Global Pruritus Therapeutics Market, by Local Anesthetics, by Region, 2019-2032 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Pruritus Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Pruritus Therapeutics Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Pruritus Therapeutics Market - North America
    • 7.3.1. North America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.2. North America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.3. Pruritus Therapeutics Market - U.S.
      • 7.3.3.1. U.S.: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.4. Pruritus Therapeutics Market - Canada
      • 7.3.4.1. Canada: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.4. Pruritus Therapeutics Market - Europe
    • 7.4.1. Europe: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.3. Pruritus Therapeutics Market - UK
      • 7.4.3.1. UK: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.4. Pruritus Therapeutics Market - France
      • 7.4.4.1. France: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.5. Pruritus Therapeutics Market - Germany
      • 7.4.5.1. Germany: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.6. Pruritus Therapeutics Market - Italy
      • 7.4.6.1. Italy: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.7. Pruritus Therapeutics Market - Spain
      • 7.4.7.1. Spain: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.8. Pruritus Therapeutics Market - Netherlands
      • 7.4.8.1. Netherlands: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.9. Pruritus Therapeutics Market - Russia
      • 7.4.9.1. Russia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.5. Pruritus Therapeutics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.3. Pruritus Therapeutics Market - China
      • 7.5.3.1. China: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.4. Pruritus Therapeutics Market - India
      • 7.5.4.1. India: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.5. Pruritus Therapeutics Market - Malaysia
      • 7.5.5.1. Malaysia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.6. Pruritus Therapeutics Market - Japan
      • 7.5.6.1. Japan: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.7. Pruritus Therapeutics Market - Indonesia
      • 7.5.7.1. Indonesia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.8. Pruritus Therapeutics Market - South Korea
      • 7.5.8.1. South Korea: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.6. Pruritus Therapeutics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.3. Pruritus Therapeutics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.4. Pruritus Therapeutics Market - UAE
      • 7.6.4.1. UAE: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.5. Pruritus Therapeutics Market - Israel
      • 7.6.5.1. Israel: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.6. Pruritus Therapeutics Market - South Africa
      • 7.6.6.1. South Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.7. Pruritus Therapeutics Market - Latin America
    • 7.7.1. Latin America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.3. Pruritus Therapeutics Market - Mexico
      • 7.7.3.1. Mexico: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.4. Pruritus Therapeutics Market - Brazil
      • 7.7.4.1. Brazil: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.5. Pruritus Therapeutics Market - Argentina
      • 7.7.5.1. Argentina: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. AbbVie Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Amgen Inc
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Astellas Pharma Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bristol Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Cara Therapeutics
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. GSK plc
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Novartis AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Pfizer Inc
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Sanofi
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Teva Pharmaceutical Industries Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Viatris Inc
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development

List of Tables

  • Table 1 Global Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 3 Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 5 North America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 7 U.S.: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 9 Canada: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 11 Europe: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 12 UK: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 13 UK: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 14 France: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 15 France: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 17 Germany: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 19 Italy: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 21 Spain: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Russia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 28 China: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 29 China: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 30 India: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 31 India: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 35 Japan: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 39 South Korea: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 45 UAE: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 47 Israel: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 49 South Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Latin America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 53 Mexico: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Brazil: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 57 Argentina: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Pruritus Therapeutics Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Product
  • Figure 7 Global Pruritus Therapeutics Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Disease Type
  • Figure 9 Global Pruritus Therapeutics Market, by Disease Type, 2022 & 2032 (USD Billion)
  • Figure 10 Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Pruritus Therapeutics Market